Mr. Dodd has served on the GeoVax Board of Directors since 2010 and assumed the role of President and Chief Executive Officer in September 2018. His executive management experience in the pharmaceutical and biotechnology industries spans more than 40 years, including executive leadership roles at Aeterna Zentaris, Inc., BioReliance Corporation, Serologicals Corporation, Solvay Pharmaceuticals, and Wyeth-Ayerst Laboratories. He is a frequently invited speaker and panelist at business and economic development conferences, as well as various conferences focused on the life sciences and pharmaceutical industry. He is a recipient of the Oglethorpe Award for UK-US Business Relationships, the Georgia BIO Industry Growth Award, and the FastTech 50 Growth Company Award (2000-2006) while leading Serologicals Corporation. Mr. Dodd holds Bachelor of Science and Master of Science degrees from Georgia State University and completed the Harvard Business School of Advanced Management Program.